Industry-Supported Plenary Presentations
Day 2, Friday, May 13th
| 08:00-08:30 | Good morning coffee |
| 08:30-09:00 | Artificial Intelligence for precision medicine in Multiple Myeloma Alberto Romagnoni – Computational Biology Team Lead Industry-supported plenary presentation |
Alberto Romagnoni
Alberto graduated as a theoretical physicist from Università degli Studi Milano-Bicocca in Italy, where he completed his PhD on deformed supersymmetric field theories. After a few years working on high energy theoretical physics as a Postdoc (at Université Paris-Sud, École polytechnique in Paris and Universidad Autonoma in Madrid), he shifted his research focus to mathematical and computational neuroscience (at Collège de France, Ecole Normale Supérieure and CNRS) and afterwards, to machine learning applied to genomic data (Inserm and Ecole Normale Supérieure). He is now a Senior Research Scientist on Owkin’s Biotech team.
Day 3, Saturday, May 14th
| 08:00-08:30 | Good morning coffee |
| 08:30-09:00 | Cellectis Driven Innovation for Patients with Relapsed/Refractory Multiple Myeloma: Development of TALEN gene-edited Allogeneic CAR-T Therapies Targeting CS1 David Sourdive, EVP, CMC & Manufacturing Roman Galetto, Senior Director, Preclinical & Program Management Kathryn Newhall, Vice President, Translational Sciences Industry-supported plenary presentation |